UPS SCS Advances In Leaders Quadrant In Gartner Magic Quadrant For 3PL, North America
May 24, 2017 13:32 pm UTC| Business
ATLANTA, May 24, 2017 -- UPS (NYSE: UPS) Supply Chain Solutions (SCS) today announced that it has advanced as a Leader in the May 2017 Gartner Magic Quadrant for Third-Party Logistics Providers, (3PL) North America. UPS...
UPS SCS Advances In Leaders Quadrant In Gartner Magic Quadrant For 3PL, North America
May 24, 2017 13:32 pm UTC| Business
ATLANTA, May 24, 2017 -- UPS (NYSE: UPS) Supply Chain Solutions (SCS) today announced that it has advanced as a Leader in the May 2017 Gartner Magic Quadrant for Third-Party Logistics Providers, (3PL) North America. UPS...
AVX Releases WBR Series Thin Film Wire Bond Resistors With Wide Customization Capabilities
May 24, 2017 13:31 pm UTC| Business
Fountain Inn, S.C., May 24, 2017 -- AVX Corporation, a leading manufacturer and supplier of passive components and interconnect solutions, has released the new WBR Series thin film wire bond resistors. Diced to small...
AVX Releases WBR Series Thin Film Wire Bond Resistors With Wide Customization Capabilities
May 24, 2017 13:31 pm UTC| Business
Fountain Inn, S.C., May 24, 2017 -- AVX Corporation, a leading manufacturer and supplier of passive components and interconnect solutions, has released the new WBR Series thin film wire bond resistors. Diced to small...
May 24, 2017 13:30 pm UTC| Business
Washington D.C., May 24, 2017 -- The Student Affairs in Higher Education Consortium (SAHEC) announces the launch of an international campaign, Where Respect Happens, for professionals, students and community members on...
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A
May 24, 2017 13:26 pm UTC| Business
- Orphan designation provides increased communication and guidance from regulators and 10-year market exclusivity upon marketing authorization -Actinium’s two leading drug candidates, Iomab-B and Actimab-A, now have orphan...
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A
May 24, 2017 13:26 pm UTC| Business
- Orphan designation provides increased communication and guidance from regulators and 10-year market exclusivity upon marketing authorization -Actinium’s two leading drug candidates, Iomab-B and Actimab-A, now have orphan...